IIT Madras’ new precision nanoinjection platform to boost breast cancer drug delivery

HealthIANS
Advertisement
New Delhi, Dec 22 : An international team of researchers led by the Indian Institute of Technology (IIT) Madras has developed a cutting-edge nanoinjection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

Breast cancer remains one of the leading causes of mortality among women worldwide.

Conventional treatments, such as chemotherapy and radiation, often harm non-cancerous tissues due to systemic drug exposure.

The new nanoinjection system delivers the anticancer drug doxorubicin directly into cancer cells using thermally stable nanoarchaeosomes (NAs) loaded into vertically aligned SiNTs etched onto a silicon wafer.

The approach creates a precise and sustained therapeutic system that minimises damage to healthy cells by combining nanoarchaeosome-based drug encapsulation with silicon nanotube (SiNT)-based intracellular delivery, said the team, including those from Monash University and Deakin University in Australia.

Experiments on in vitro (cell culture) and ex ovo (chick embryo) models, published in the journal Advanced Materials Interfaces, demonstrated that the NAD-SiNTs (Nanoarchaeosome-Doxorubicin-Silicon nanotubes) induced strong cytotoxicity against MCF-7 breast cancer cells, while sparing healthy fibroblasts.

The NAD-SiNTs triggered cell-cycle arrest and necrosis in cancer cells and significantly reduced angiogenesis, the process through which tumours develop new blood vessels, by downregulating key pro-angiogenic factors.

The platform demonstrated 23 times lower inhibitory concentration (IC50) than free doxorubicin, suggesting higher potency at much lower doses, which can directly translate into lower treatment costs and fewer side effects.

“This research could have transformative implications for healthcare delivery in low- and middle-income countries like India, where access to advanced cancer therapies remains limited by cost. By enabling targeted delivery of smaller doses with higher efficacy, the system can potentially lower the overall expense of cancer treatment and improve patients’ quality of life,” said Dr. Swathi Sudhakar, Assistant Professor, Department of Applied Mechanics and Biomedical Engineering, IIT Madras.

“The platform also aligns with national goals for affordable healthcare innovation and could eventually be adapted for use in treating other forms of cancer,” she added.

Unlike other nanoinjection platforms made from carbon or titanium nanotubes, the silicon nanotube-based design is inherently biocompatible and non-toxic, reducing the need for additional surface modifications. This makes it a more reliable and scalable candidate for future clinical translation.

The next phase of research will focus on in vivo validation, long-term toxicity studies, and regulatory assessments to prepare for preclinical and clinical translation.

Advertisement

Note: The content of this article is sourced from a news agency and has not been edited by the ap7am team.

IIT-MadrasBreast CancerNanoinjectionDrug DeliveryDoxorubicinNanoarchaeosomesSilicon NanotubesSwathi SudhakarCancer TreatmentTargeted Therapy

More News

Telangana’s 4,000 MW Yadadri plant to achieve full capacity soon

17 Nov, 19:01

Reports of unwanted Instagram recommendations in India halved over past year: Meta

17 Nov, 19:00

Trump watches as PM Modi picks up Indian flag marker from floor, video goes viral

17 Nov, 18:58

Rajinikanth's daughter Soundarya shares pictures of their family getaway in Greece; says 'What amazing memories we’ve made in Athens!'

17 Nov, 18:56

When Jackie Shroff gave 10x returns to Archana Puran Singh on pending principal amount from struggling days

17 Nov, 18:54

'There was no one like Dhoni, and can't see anyone in next 10 years either': Coach MP Singh

17 Nov, 18:53

Dulquer Salmaan's 'Aakasamlo Oka Tara' cleared for release with U/A certificate

17 Nov, 18:52

Gas leak from ONGC well in Andhra brought under control

17 Nov, 18:50

‘Learned the meaning of simplicity…’: Ruturaj Gaikwad’s heartfelt tribute to Dhoni

17 Nov, 18:49

Dhanush, Mammootty-starrer 'Om' cleared for release with U/A certificate!

17 Nov, 18:47

Sri Lanka lose 15 WTC points, Pakistan docked five for slow over-rate during Rawalpindi Test

17 Nov, 18:46

'IPL will not be the same': Cricket fraternity pays emotional tribute to MS Dhoni after retirement

17 Nov, 18:44

Rahul Gandhi responds to backlash over 'lap' remark, shares temple sculpture

17 Nov, 18:43

PM Modi is 'a very tough man': Trump after meeting Quad counterparts

17 Nov, 17:06

Drug cartels turn to private players, DIY videos to evade crackdown; agencies flag new trend

17 Nov, 17:05

Gurnoor Brar reprimanded for Code of Conduct breach, handed one demerit point

17 Nov, 17:03

Why did Telangana find no mention in Sonia Gandhi’s book: BRS

17 Nov, 17:02

MS Dhoni’s IPL legacy: Five titles, 5,439 runs and several records

17 Nov, 16:57

Nifty hits 9-month high, Bank Nifty scales record peak as market rally extends

17 Nov, 16:00

Dhoni quietly said, ‘Maybe you should add my name' in release list, reveals CSK owner Rupa Gurunath

17 Nov, 15:46
..More News